Y Çakıroğlu1, F Vural2, B Vural1. 1. Obstetrics and Gynecology Department, Kocaeli University School of Medicine, Kocaeli, Turkey. 2. Obstetrics and Gynecology Clinic, Haydarpaşa Numune Training and Research Hospital, Istanbul, Turkey. fisunvural@yahoo.com.tr.
Abstract
OBJECTIVE: To investigate the inflammatory markers in polycystic ovary syndrome (PCOS) and associations of these markers with obesity and in vitro fertilization (IVF) outcomes. METHODS: A total of 292 women underwent IVF procedure either with PCOS (n = 146) or without PCOS (n = 146, age, and body mass index (BMI) matched controls) were included in the study. All patients were classified according to BMI levels (normal weight: NW, BMI <25 kg/m(2) and obese: OB, BMI ≥25 kg/m(2)). The inflammatory markers were leukocyte count, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), mean platelet volume (MPV). RESULTS: BMI of PCOS was positively correlated with leukocyte, neutrophil, lymphocyte and MPV (p < 0.05), but negatively correlated with NLR and PLR (p < 0.05). Both NLR and PLR increased significantly in PCOS (p < 0.001). PLR increased significantly in NW-PCOS compared the NW-controls and OB-PCOS. MPV values increased only in OB-PCOS subjects. The logistic regression analyzes showed that MPV was the independent variable in PCOS to effect CPR (p = 0.000; OR 0.1; CI 0.06-0.2). CONCLUSIONS: NLR and PLR were significantly increased in all PCOS subjects compared to the BMI-matched controls. Despite PLR being decreased by adiposity, PLR increased in NW-PCOS. These results are supporting the hypothesis that PCOS is a chronic inflammatory process independent of obesity. MPV levels were independently associated with CPR in PCOS. Further prospective studies concerning inflammation and IVF outcomes of PCOS are needed.
OBJECTIVE: To investigate the inflammatory markers in polycystic ovary syndrome (PCOS) and associations of these markers with obesity and in vitro fertilization (IVF) outcomes. METHODS: A total of 292 women underwent IVF procedure either with PCOS (n = 146) or without PCOS (n = 146, age, and body mass index (BMI) matched controls) were included in the study. All patients were classified according to BMI levels (normal weight: NW, BMI <25 kg/m(2) and obese: OB, BMI ≥25 kg/m(2)). The inflammatory markers were leukocyte count, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), mean platelet volume (MPV). RESULTS: BMI of PCOS was positively correlated with leukocyte, neutrophil, lymphocyte and MPV (p < 0.05), but negatively correlated with NLR and PLR (p < 0.05). Both NLR and PLR increased significantly in PCOS (p < 0.001). PLR increased significantly in NW-PCOS compared the NW-controls and OB-PCOS. MPV values increased only in OB-PCOS subjects. The logistic regression analyzes showed that MPV was the independent variable in PCOS to effect CPR (p = 0.000; OR 0.1; CI 0.06-0.2). CONCLUSIONS: NLR and PLR were significantly increased in all PCOS subjects compared to the BMI-matched controls. Despite PLR being decreased by adiposity, PLR increased in NW-PCOS. These results are supporting the hypothesis that PCOS is a chronic inflammatory process independent of obesity. MPV levels were independently associated with CPR in PCOS. Further prospective studies concerning inflammation and IVF outcomes of PCOS are needed.
Authors: Arnoud J Templeton; Olga Ace; Mairéad G McNamara; Mustafa Al-Mubarak; Francisco E Vera-Badillo; Thomas Hermanns; Boštjan Seruga; Alberto Ocaña; Ian F Tannock; Eitan Amir Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-05-03 Impact factor: 4.254
Authors: Francesco Giallauria; Francesco Orio; Gaetano Lombardi; Annamaria Colao; Carlo Vigorito; Maria Giovanna Tafuri; Stefano Palomba Journal: J Ovarian Res Date: 2009-02-02 Impact factor: 4.234
Authors: A L L Rocha; L C Faria; T C M Guimarães; G V Moreira; A L Cândido; C A Couto; F M Reis Journal: J Endocrinol Invest Date: 2017-06-13 Impact factor: 4.256
Authors: Norbert Gleicher; Vitaly A Kushnir; Sarah K Darmon; Qi Wang; Lin Zhang; David F Albertini; David H Barad Journal: Endocrine Date: 2018-01-06 Impact factor: 3.633
Authors: B Hossein Rashidi; S Shams; M Shariat; H Kazemi Jaliseh; M Mohebi; F Haghollahi Journal: J Endocrinol Invest Date: 2017-03-08 Impact factor: 4.256
Authors: S Behboudi-Gandevani; F Ramezani Tehrani; R Bidhendi Yarandi; M Noroozzadeh; M Hedayati; F Azizi Journal: J Endocrinol Invest Date: 2017-03-22 Impact factor: 4.256
Authors: Mustafa Suat Bolat; Sırrı S Bilge; Ekrem Akdeniz; Onder Cinar; Fatih Firat; Arzu Erdal Agri; Mustafa Bakirtas; Omer Alici; Fikret Erdemir Journal: Biomed Res Int Date: 2017-10-19 Impact factor: 3.411